CGEM
Analyzing Cullinan Therapeutics Inc (CGEM) After Recent Trading Activity
Cullinan Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Michaelson Jennifer unloaded Company’s shares for reported $49200.0 on ...
Examining the Potential Price Growth of Cullinan Therapeutics Inc (CGEM)
Cullinan Therapeutics Inc’s recently made public that its Chief Scientific Officer Michaelson Jennifer unloaded Company’s shares for reported $49200.0 on ...
Potential Price Increase for Cullinan Therapeutics Inc (CGEM) After Recent Insider Activity
In a filing, Cullinan Therapeutics Inc revealed its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.39 ...
CGEM stock rated a Buy by H.C. Wainwright
Cullinan Therapeutics Inc’s recent filing unveils that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.39 ...
Potential Price Increase for Cullinan Therapeutics Inc (CGEM) After Recent Insider Activity
In a filing, Cullinan Therapeutics Inc revealed its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.39 ...
Investing in Cullinan Therapeutics Inc (CGEM): What You Must Know
Cullinan Therapeutics Inc’s filing revealed that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.39 million ...
H.C. Wainwright gives a Buy recommendation for Cullinan Therapeutics Inc (CGEM)
In a filing, Cullinan Therapeutics Inc revealed its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.33 ...
